wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q40729988-1BBBB6A5-415D-4EF7-95BA-469ECCA21103
Q40729988-1BBBB6A5-415D-4EF7-95BA-469ECCA21103
BestRank
Statement
http://www.wikidata.org/entity/statement/Q40729988-1BBBB6A5-415D-4EF7-95BA-469ECCA21103
Nonalcoholic fatty liver disease: from lipid profile to treatment.
P2860
Q40729988-1BBBB6A5-415D-4EF7-95BA-469ECCA21103
BestRank
Statement
http://www.wikidata.org/entity/statement/Q40729988-1BBBB6A5-415D-4EF7-95BA-469ECCA21103
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
5fdcb61593b26791d2be5dcb3c1aef3fa646ca46
P2860
NPC1L1 inhibitor ezetimibe is a reliable therapeutic agent for non-obese patients with nonalcoholic fatty liver disease.